Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3Urogenital Neoplasms 1Smoldering Multiple Myeloma 1Sarcoma 1Prostatic Neoplasms 1Peripheral Nervous System Diseases 1Neoplasms 1Monoclonal Gammopathy of Undetermined Significance 1Melanoma 1Lung Neoplasms 1Leukemia, Myeloid, Chronic-Phase 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypertension 1Head and Neck Neoplasms 1Diabetes Mellitus 1Depressive Disorder, Major 1Depression 1Colorectal Neoplasms 1Cardiovascular Diseases 1

Interventions

Secretin 1Preventive Health Services 1Pioglitazone 1Observation 1Metformin 1Fenofibrate 1Fatty Acids, Omega-3 1Desvenlafaxine Succinate 1Adrenalectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Diabetes Mellitus × Fatty Acids, Omega-3 × Clear all
NCT01803711 2017-12-27

Omega 3 FA Supplements as Augmentation in the Treatment of Depression

UConn Health

Phase 2/3 Terminated
6 enrolled 4 charts

Cardiovascular Diseases, Depression, Depressive Disorder, Major, Diabetes Mellitus, Hypertension, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡